Pesquisas alternativas:
company phase » company case (Expandir a Pesquisa), company has (Expandir a Pesquisa), compliant phase (Expandir a Pesquisa)
complex cell » complex cells (Expandir a Pesquisa), complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa)
compere can » compared can (Expandir a Pesquisa), compere jean (Expandir a Pesquisa), complete can (Expandir a Pesquisa)
oil complex » msl complex (Expandir a Pesquisa), novel complex (Expandir a Pesquisa), model complex (Expandir a Pesquisa)
us company » gas company (Expandir a Pesquisa), _ company (Expandir a Pesquisa), a company (Expandir a Pesquisa)
l compere » w compere (Expandir a Pesquisa), l comper (Expandir a Pesquisa), l cooper (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
cell now » cells now (Expandir a Pesquisa), cell know (Expandir a Pesquisa), cell non (Expandir a Pesquisa)
a us » _ us (Expandir a Pesquisa), a un (Expandir a Pesquisa), a uk (Expandir a Pesquisa)
company phase » company case (Expandir a Pesquisa), company has (Expandir a Pesquisa), compliant phase (Expandir a Pesquisa)
complex cell » complex cells (Expandir a Pesquisa), complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa)
compere can » compared can (Expandir a Pesquisa), compere jean (Expandir a Pesquisa), complete can (Expandir a Pesquisa)
oil complex » msl complex (Expandir a Pesquisa), novel complex (Expandir a Pesquisa), model complex (Expandir a Pesquisa)
us company » gas company (Expandir a Pesquisa), _ company (Expandir a Pesquisa), a company (Expandir a Pesquisa)
l compere » w compere (Expandir a Pesquisa), l comper (Expandir a Pesquisa), l cooper (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
cell now » cells now (Expandir a Pesquisa), cell know (Expandir a Pesquisa), cell non (Expandir a Pesquisa)
a us » _ us (Expandir a Pesquisa), a un (Expandir a Pesquisa), a uk (Expandir a Pesquisa)
1
Por Pilar Taberner Bonastre, María Teresa Taberner Bonastre, Enrique Soler Company, María Dolores Pérez-Serrano Lainosa
Publicado no Farmacia Hospitalaria (2016)
“...Objective: ensure a good quality of life in the last phase of onco- hematological patients should...”Publicado no Farmacia Hospitalaria (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“... and importance with over 400() already marketed in the U.S. and European markets alone. Many companies throughout...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Stergiopoulos, Stella, Calvert, Sara B, Brown, Carrie A, Awatin, Josephine, Tenaerts, Pamela, Holland, Thomas L, DiMasi, Joseph A, Getz, Kenneth A
Publicado no Clin Infect Dis (2018)
“..., representatives from industry, and the US Food and Drug Administration, we conducted a study to (1) evaluate...”Publicado no Clin Infect Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
5
Por Ayers, A.
Publicado em 2010
“... with currently available “non-specific” medications which is expected to create a compelling value proposition...”Publicado em 2010
Obter o texto integral
Artigo
6
Por Hess, Lisa M., Rajan, Narayan, Winfree, Katherine, Davey, Peter, Ball, Mark, Knox, Hediyyih, Graham, Christopher
Publicado no Adv Ther (2015)
“... in either the United States (US) or Japan. This study was designed as a cross-country evaluation of cost...”Publicado no Adv Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Beigel, John H, Tebas, Pablo, Elie-Turenne, Marie-Carmelle, Bajwa, Ednan, Bell, Todd E, Cairns, Charles B, Shoham, Shmuel, Deville, Jaime G, Feucht, Eric, Feinberg, Judith, Luke, Thomas, Raviprakash, Kanakatte, Danko, Janine, O'Neil, Dorothy, Metcalf, Julia A, King, Karen, Burgess, Timothy H, Aga, Evgenia, Lane, H Clifford, Hughes, Michael D, Davey, Richard T
Publicado no Lancet Respir Med (2017)
“... effect of plasma treatment on the primary endpoint, the treatment seemed safe and well tolerated. A phase...”Publicado no Lancet Respir Med (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Glimm, A-M, Werner, S G, Burmester, G R, Backhaus, M, Ohrndorf, S
Publicado no Ann Rheum Dis (2016)
“... inflammatory changes are mainly present in PIP and distal interphalangeal (DIP) joints. Joint inflammation can...”Publicado no Ann Rheum Dis (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Embree, Genevieve G R, Samuel-Hodge, Carmen D, Johnston, Larry F, Garcia, Beverly A, Gizlice, Ziya, Evenson, Kelly R, DeWalt, Darren A, Ammerman, Alice S, Keyserling, Thomas C
Publicado no BMJ Open Diabetes Res Care (2017)
“...: The intervention included: Phase I (months 1–6), an individually tailored intervention promoting a Mediterranean...”Publicado no BMJ Open Diabetes Res Care (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Smith, Barry H., Gazda, Lawrence S., Fahey, Thomas J., Nazarian, Angelica, Laramore, Melissa A., Martis, Prithy, Andrada, Zoe P., Thomas, Joanne, Parikh, Tapan, Sureshbabu, Sudipta, Berman, Nathaniel, Ocean, Allyson J., Hall, Richard D., Wolf, David J.
Publicado no Chin J Cancer Res (2018)
“...OBJECTIVE: The complexity, heterogeneity and capacity of malignant neoplastic cells and tumors...”Publicado no Chin J Cancer Res (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“...A phase-contrast X-ray microtomography system using the Talbot imaging has been built at the SPring...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por García-Salinas, Sara, Elizondo-Castillo, Hellen, Arruebo, Manuel, Mendoza, Gracia, Irusta, Silvia
Publicado no Molecules (2018)
“...Even though essential oils (EOs) have been used for therapeutic purposes, there is now a renewed...”Publicado no Molecules (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Kumsa, Doe, Steinke, G. Karl, Molnar, Gregory F., Hudak, Eric M., Montague, Fred W., Kelley, Shawn C., Untereker, Darrel F., Shi, Alan, Hahn, Benjamin P., Condit, Chris, Lee, Hyowon, Bardot, Dawn, Centeno, Jose A., Krauthamer, Victor, Takmakov, Pavel A.
Publicado no Neuromodulation (2017)
“...OBJECTIVE: The Shannon model is often used to define an expected boundary between non-damaging...”Publicado no Neuromodulation (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Cipriani, Andrea, Purgato, Marianna, Furukawa, Toshi A, Trespidi, Carlotta, Imperadore, Giuseppe, Signoretti, Alessandra, Churchill, Rachel, Watanabe, Norio, Barbui, Corrado
Publicado em 2012
“...BACKGROUND: Recent US and UK clinical practice guidelines recommend that second-generation...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“... (SOTs) is estimated as 8–9 times higher than the rate in the overall US population (3.2/1000 person...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Людмила Владимировна Шкулипа
Publicado em 2016-11-01
Assuntos:
“...non-financial reporting...”Publicado em 2016-11-01
Obter o texto integral
Artigo
17
“... chemotherapy (chemo) is estimated as 3–4 times higher than in the overall US population (3.2/1000 person-years...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Beibei Zhu, Yi Liu, Jing Li, Qi Ni, Zheng Yin, Junli Zhu, Ken Chen, Xueyuan Yang
Publicado em 2022-04-01
“...-reported outcome for non–phase I or II trials only) information were extracted and analyzed.Results: A...”Publicado em 2022-04-01
Obter o texto integral
Artigo
19
20
Por Papathanasiou, Maria, Lambaki, Sofia, Porpodis, Konstantinos, Spyratos, Dionysios, Tryfon, Stayros, Zarogoulidis, Paulos, Eleytheriadoy, Ellada, Kontakiotis, Theodoros
Publicado no Ann Transl Med (2016)
“...The non-small cell lung cancer (NSCLC) accounts approximately 85% of lung cancers and includes...”Publicado no Ann Transl Med (2016)
Obter o texto integral
Obter o texto integral
Artigo